Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Gekeler

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Molecular Pharmacology|July 1, 1995
B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoproteinC Borchers, W R Ulrich, K Klemm, et al.
British Journal of Cancer|September 1, 1992
Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemiasV Gekeler, G Frese, A Noller, et al.
British Journal of Cancer|September 1, 1996
Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistanceV Gekeler, R Boer, F Uberall, et al.
British Journal of Cancer|January 24, 2008
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomyW Weichert, A Röske, V Gekeler, et al.
Leukemia Research|June 22, 1999
Functional analysis of P-glycoprotein and multidrug resistance associated protein related multidrug resistance in AML-blastsD Brügger, H Herbart, V Gekeler, et al.
British Journal of Cancer|July 12, 2007
High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosisW Weichert, M Boehm, V Gekeler, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Molecular Pharmacology|July 1, 1995
B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoproteinC Borchers, W R Ulrich, K Klemm, et al.
British Journal of Cancer|September 1, 1992
Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemiasV Gekeler, G Frese, A Noller, et al.
British Journal of Cancer|September 1, 1996
Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistanceV Gekeler, R Boer, F Uberall, et al.
British Journal of Cancer|January 24, 2008
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomyW Weichert, A Röske, V Gekeler, et al.
Leukemia Research|June 22, 1999
Functional analysis of P-glycoprotein and multidrug resistance associated protein related multidrug resistance in AML-blastsD Brügger, H Herbart, V Gekeler, et al.
British Journal of Cancer|July 12, 2007
High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosisW Weichert, M Boehm, V Gekeler, et al.
Pageof 6